<VariationArchive VariationID="218091" VariationName="NM_033453.4(ITPA):c.359_366dup (p.Gly123fs)" VariationType="Duplication" Accession="VCV000218091" Version="28" RecordType="classified" NumberOfSubmissions="9" NumberOfSubmitters="9" DateLastUpdated="2024-07-29" DateCreated="2015-11-22" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="214745" VariationID="218091">
      <GeneList>
        <Gene Symbol="ITPA" FullName="inosine triphosphatase" GeneID="3704" HGNC_ID="HGNC:6176" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="3204065" stop="3227449" display_start="3204065" display_stop="3227449" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="3189513" stop="3204515" display_start="3189513" display_stop="3204515" Strand="+" />
          </Location>
          <OMIM>147520</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_033453.4(ITPA):c.359_366dup (p.Gly123fs)</Name>
      <CanonicalSPDI>NC_000020.11:3218578:CTCAGCACC:CTCAGCACCTCAGCACC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>20p13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="3218578" stop="3218579" display_start="3218578" display_stop="3218579" variantLength="8" positionVCF="3218578" referenceAlleleVCF="A" alternateAlleleVCF="ACTCAGCAC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="3199224" stop="3199225" display_start="3199224" display_stop="3199225" variantLength="8" positionVCF="3199224" referenceAlleleVCF="A" alternateAlleleVCF="ACTCAGCAC" />
      </Location>
      <ProteinChange>G106fs</ProteinChange>
      <ProteinChange>G82fs</ProteinChange>
      <ProteinChange>G11fs</ProteinChange>
      <ProteinChange>G123fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.3218580_3218587dup" Assembly="GRCh38">
            <Expression>NC_000020.11:g.3218580_3218587dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.3199226_3199233dup" Assembly="GRCh37">
            <Expression>NC_000020.10:g.3199226_3199233dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012093.2" sequenceAccession="NG_012093" sequenceVersion="2" change="g.14714_14721dup">
            <Expression>NG_012093.2:g.14714_14721dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001267623.2" sequenceAccession="NM_001267623" sequenceVersion="2" change="c.236_243dup">
            <Expression>NM_001267623.2:c.236_243dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001254552.1" sequenceAccession="NP_001254552" sequenceVersion="1" change="p.Gly82fs">
            <Expression>NP_001254552.1:p.Gly82fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001324236.2" sequenceAccession="NM_001324236" sequenceVersion="2" change="c.22_29dup">
            <Expression>NM_001324236.2:c.22_29dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001311165.1" sequenceAccession="NP_001311165" sequenceVersion="1" change="p.Gly11fs">
            <Expression>NP_001311165.1:p.Gly11fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001324237.2" sequenceAccession="NM_001324237" sequenceVersion="2" change="c.22_29dup">
            <Expression>NM_001324237.2:c.22_29dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001311166.1" sequenceAccession="NP_001311166" sequenceVersion="1" change="p.Gly11fs">
            <Expression>NP_001311166.1:p.Gly11fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001324238.2" sequenceAccession="NM_001324238" sequenceVersion="2" change="c.22_29dup">
            <Expression>NM_001324238.2:c.22_29dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001311167.1" sequenceAccession="NP_001311167" sequenceVersion="1" change="p.Gly11fs">
            <Expression>NP_001311167.1:p.Gly11fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001324240.2" sequenceAccession="NM_001324240" sequenceVersion="2" change="c.359_366dup">
            <Expression>NM_001324240.2:c.359_366dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001311169.1" sequenceAccession="NP_001311169" sequenceVersion="1" change="p.Gly123fs">
            <Expression>NP_001311169.1:p.Gly123fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351739.2" sequenceAccession="NM_001351739" sequenceVersion="2" change="c.22_29dup">
            <Expression>NM_001351739.2:c.22_29dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338668.1" sequenceAccession="NP_001338668" sequenceVersion="1" change="p.Gly11fs">
            <Expression>NP_001338668.1:p.Gly11fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033453.4" sequenceAccession="NM_033453" sequenceVersion="4" change="c.359_366dup" MANESelect="true">
            <Expression>NM_033453.4:c.359_366dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_258412.1" sequenceAccession="NP_258412" sequenceVersion="1" change="p.Gly123fs">
            <Expression>NP_258412.1:p.Gly123fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181493.4" sequenceAccession="NM_181493" sequenceVersion="4" change="c.308_315dup">
            <Expression>NM_181493.4:c.308_315dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852470.1" sequenceAccession="NP_852470" sequenceVersion="1" change="p.Gly106fs">
            <Expression>NP_852470.1:p.Gly106fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_052000.2" sequenceAccession="NR_052000" sequenceVersion="2" change="n.586_593dup">
            <Expression>NR_052000.2:n.586_593dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_052002.2" sequenceAccession="NR_052002" sequenceVersion="2" change="n.348_355dup">
            <Expression>NR_052002.2:n.348_355dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033453.3" sequenceAccession="NM_033453" sequenceVersion="3" change="c.359_366dupTCAGCACC">
            <Expression>NM_033453.3:c.359_366dupTCAGCACC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA279834" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="147520.0006" DB="OMIM" />
        <XRef Type="rs" ID="1407446171" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_033453.4(ITPA):c.359_366dup (p.Gly123fs) AND Developmental and epileptic encephalopathy, 35" Accession="RCV000202316" Version="15">
        <ClassifiedConditionList TraitSetID="23315">
          <ClassifiedCondition DB="MedGen" ID="C4225256">Developmental and epileptic encephalopathy, 35</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-21" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033453.4(ITPA):c.359_366dup (p.Gly123fs) AND Inosine triphosphatase deficiency" Accession="RCV001070704" Version="6">
        <ClassifiedConditionList TraitSetID="4075">
          <ClassifiedCondition DB="MedGen" ID="C0342800">Inosine triphosphatase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033453.4(ITPA):c.359_366dup (p.Gly123fs) AND not provided" Accession="RCV001008848" Version="12">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-11-01" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033453.4(ITPA):c.359_366dup (p.Gly123fs) AND Partial congenital absence of teeth" Accession="RCV001526600" Version="4">
        <ClassifiedConditionList TraitSetID="23769">
          <ClassifiedCondition DB="MedGen" ID="C0020608">Partial congenital absence of teeth</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-21" NumberOfSubmissions="9" NumberOfSubmitters="9" DateCreated="2015-11-22" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26224535</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30542205</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30856165</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34989426</ID>
        </Citation>
        <DescriptionHistory Dated="2021-01-30">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-04-15">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-03-14">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="4075" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="11392" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">INOSINE TRIPHOSPHATE PYROPHOSPHOHYDROLASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="613850" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Inosine triphosphatase deficiency</ElementValue>
                <XRef ID="Inosine+triphosphatase+deficiency/8673" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013461" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Inosine triphosphate pyrophosphohydrolase (ITPase) deficiency is a common inherited condition characterized by the abnormal accumulation of inosine triphosphate (ITP) in erythrocytes (Sumi et al., 2002).</Attribute>
                <XRef Type="MIM" ID="613850" DB="OMIM" />
              </AttributeSet>
              <XRef ID="C0342800" DB="MedGen" />
              <XRef ID="MONDO:0013461" DB="MONDO" />
              <XRef Type="MIM" ID="613850" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="23769" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33410" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hypodontia</ElementValue>
                <XRef ID="HP:0000668" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Partial congenital absence of teeth</ElementValue>
                <XRef ID="Tooth+agenesis%2C+selective%2C+1/9411" DB="Genetic Alliance" />
                <XRef ID="64969001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TOOTH AGENESIS, FAMILIAL</ElementValue>
                <XRef Type="MIM" ID="106600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tooth agenesis, selective</ElementValue>
                <XRef Type="Phenotypic series" ID="PS106600" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16908" />
                <XRef ID="16908" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000324344" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <XRef ID="99798" DB="Orphanet" />
              <XRef ID="C0020608" DB="MedGen" />
              <XRef ID="MONDO:0005486" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS106600" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000668" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="23315" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34425" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 35</ElementValue>
                <XRef ID="MONDO:0014719" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 35</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE35</ElementValue>
                <XRef Type="MIM" ID="616647" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17806" />
                <XRef ID="17806" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="457375" DB="Orphanet" />
              <XRef ID="C4225256" DB="MedGen" />
              <XRef ID="MONDO:0014719" DB="MONDO" />
              <XRef Type="MIM" ID="616647" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1142510" SubmissionDate="2017-08-04" DateLastUpdated="2018-05-31" DateCreated="2018-05-31">
        <ClinVarSubmissionID localKey="ACP18_ITPA_v1|OMIM:616647" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000586836" DateUpdated="2018-05-31" DateCreated="2018-05-31" Type="SCV" Version="1" SubmitterName="TIDEX, University of British Columbia" OrgID="506168" OrganizationCategory="clinic" OrgAbbreviation="TIDEX" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITPA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="20" alternateAllele="TCAGCACC" referenceAllele="-" start="3199226" stop="3199233" variantLength="8" />
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="863225424" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033453.3:c.359_366dupTCAGCACC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616647" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2628449</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1334640" SubmissionDate="2017-12-18" DateLastUpdated="2015-11-23" DateCreated="2015-11-23">
        <ClinVarSubmissionID localKey="136-20171218" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000680264" DateUpdated="2015-11-23" DateCreated="2015-11-23" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München" OrgID="500240" OrganizationCategory="clinic" OrgAbbreviation="IHG-MRI-TUM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Classification criteria August 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/inodbbrd/classification_criteria.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Tissue>blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
              <FamilyData PedigreeID="38" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">38</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITPA" />
          </GeneList>
          <VariantType>Insertion</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="20" alternateAllele="CTCAGCAC" referenceAllele="-" start="3199224" stop="3199225" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616647" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="480217" SubmissionDate="2020-10-23" DateLastUpdated="2015-11-22" DateCreated="2015-11-22">
        <ClinVarSubmissionID localKey="147520.0006_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35" title="ITPA, 8-BP DUP, NT359_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35" />
        <ClinVarAccession Accession="SCV000257323" DateUpdated="2015-11-22" DateCreated="2015-11-22" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient of Roma origin (family IV) with developmental and epileptic encephalopathy-35 (DEE35; 616647), Kevelam et al. (2015) identified a homozygous 8-bp duplication (c.359_366dupTCAGCACC, NM_033453.3) in exon 6 of the ITPA gene, resulting in a frameshift (Gly123SerfsTer104), that would result in an extended protein of 225 amino acids instead of 194 amino acids. The mutation segregated with the disorder in the family and was not found in the dbSNP (build 137), 1000 Genomes Project, Exome Variant Server, or in-house control exome databases, but was reported in the heterozygous state in 1 Bulgarian control individual. Patient fibroblasts showed 2.9% residual ITPA activity without accumulation of ITP. The patient presented at birth with hypotonia and irritability. She developed refractory seizures at 5 months of age.</Attribute>
              <Citation>
                <ID Source="PubMed">26224535</ID>
              </Citation>
              <XRef DB="OMIM" ID="616647" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITPA" />
          </GeneList>
          <Name>ITPA, 8-BP DUP, NT359</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">8-BP DUP, NT359</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="147520.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2306646" SubmissionDate="2019-10-15" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDX:1744888|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001168653" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The c.359_366dupTCAGCAC variant in the ITPA gene has been reported previously, in the homozygous state, in an individual with early onset encephalopathy who had 2.9% residual ITPA enzyme activity compared to wild type controls (Kevelam et al., 2015). This variant was also reported in the heterozygous state in a healthy individual who had 30% residual ITPA enzyme activity compared to wild type controls (Atanasova et al., 2007). The c.359_366dupTCAGCAC variant causes a frameshift starting with codon Glycine 123, changes this amino acid to a Serine residue, and creates a premature Stop codon at position 104 of the new reading frame, denoted p.Gly123SerfsX104. This variant is predicted to cause loss of normal protein function as the last 72 amino acids are lost and replaced with 103 incorrect amino acids. The c.359_366dupTCAGCAC variant is observed in 6/125,736 (0.005%) alleles from individuals of European background, in large population cohorts (Lek et al., 2016).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITPA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033453.3:c.359_366dupTCAGCACC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3414333" SubmissionDate="2021-06-14" DateLastUpdated="2021-06-19" DateCreated="2021-06-19">
        <ClinVarSubmissionID localKey="PED7200.1|HPO:HP:0000668" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001737029" DateUpdated="2021-06-19" DateCreated="2021-06-19" Type="SCV" Version="1" SubmitterName="Equipe Genetique des Anomalies du Developpement, Université de Bourgogne" OrgID="506039" OrganizationCategory="laboratory" OrgAbbreviation="GADteam" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITPA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033453.4:c.359_366dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="HP" ID="HP:0000668" />
          </Trait>
        </TraitSet>
        <Comment>Homozygous, both variants are inherited from each parent</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB9847331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4041492" SubmissionDate="2022-02-10" DateLastUpdated="2022-02-11" DateCreated="2022-01-22">
        <ClinVarSubmissionID localKey="53604579|OMIM:616647" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002061613" DateUpdated="2022-02-11" DateCreated="2022-01-22" Type="SCV" Version="2" SubmitterName="Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center" OrgID="1019" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PVS1, PS3, PM2</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITPA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033453.4:c.359_366dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616647" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10978824</SubmissionName>
          <SubmissionName>SUB11067454</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2401633" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4061548|MedGen:C1840173" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001235971" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26224535</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26224535</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30856165</ID>
          </Citation>
          <Comment>This sequence change results in a frameshift in the ITPA gene (p.Gly123Serfs*104). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 72 amino acid(s) of the ITPA protein and extend the protein by 31 additional amino acid residues. This variant is present in population databases (rs763029259, gnomAD 0.01%). This frameshift has been observed in individual(s) with ITPA-related conditions (PMID: 26224535). ClinVar contains an entry for this variant (Variation ID: 218091). This variant disrupts a region of the ITPA protein in which other variant(s) (p.Trp151*) have been determined to be pathogenic (PMID: 26224535, 30856165). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITPA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.3199224_3199225insCTCAGCAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1840173" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5509354" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2023-01-21">
        <ClinVarSubmissionID localKey="126320|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002821059" DateUpdated="2024-07-15" DateCreated="2023-01-21" Type="SCV" Version="11" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ITPA: PVS1, PM2, PM3</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITPA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="20" alternateAllele="ACTCAGCAC" referenceAllele="A" start="3199224" stop="3199224" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9874908" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_033453_3_ITPA_c_359_366dupTCAGCACC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005086680" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26224535</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30542205</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34989426</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with developmental and epileptic encephalopathy 35 (MIM#616647). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0208 - Variant is predicted to result in an elongated protein. (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) &lt;0.01 for a recessive condition (10 heterozygotes, 0 homozygotes). (SP) 0600 - Variant affects part of the annotated Ham1 family domain (DECIPHER). (I) 0704 - Another protein elongation variant comparable to the one identified in this case has limited previous evidence for pathogenicity. This variant has been reported twice as likely pathogenic and pathogenic, while other elongations found further downstream have been reported as VUS (ClinVar). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported multiple times as likely pathogenic and pathogenic, and observed in compound heterozygous and homozygous individuals with early-infantile epileptic encephalopathy, atypical cerebral palsy or myotonic seizures with microcephaly and global developmental delay (ClinVar, PMID: 26224535, PMID: 30542205, PMID: 34989426). (SP) 1001 - This variant has strong functional evidence supporting abnormal protein function. Fibroblasts from a homozygous individual had only 2.9% residual enzyme activity (PMID: 26224535). (SP) 1201 - Heterozygous variant detected in trans with a likely pathogenic heterozygous variant (p.(Asp109Tyr)) in a recessive disease. (I) 1205 - This variant has been shown to be maternally inherited (by duo analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITPA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_23567</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033453.3:c.359_366dupTCAGCACC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616647" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9874908" TraitType="Disease" MappingType="XRef" MappingValue="616647" MappingRef="OMIM">
        <MedGen CUI="C4225256" Name="Developmental and epileptic encephalopathy, 35" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1334640" TraitType="Disease" MappingType="XRef" MappingValue="616647" MappingRef="OMIM">
        <MedGen CUI="C4225256" Name="Developmental and epileptic encephalopathy, 35" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2401633" TraitType="Disease" MappingType="XRef" MappingValue="C1840173" MappingRef="MedGen">
        <MedGen CUI="C0342800" Name="Inosine triphosphatase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="480217" TraitType="Disease" MappingType="Name" MappingValue="DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35" MappingRef="Preferred">
        <MedGen CUI="C4225256" Name="Developmental and epileptic encephalopathy, 35" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4041492" TraitType="Disease" MappingType="XRef" MappingValue="616647" MappingRef="OMIM">
        <MedGen CUI="C4225256" Name="Developmental and epileptic encephalopathy, 35" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5509354" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3414333" TraitType="Disease" MappingType="XRef" MappingValue="HP:0000668" MappingRef="HP">
        <MedGen CUI="C0020608" Name="Partial congenital absence of teeth" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2306646" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1142510" TraitType="Disease" MappingType="XRef" MappingValue="616647" MappingRef="OMIM">
        <MedGen CUI="C4225256" Name="Developmental and epileptic encephalopathy, 35" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

